Medical devices having inorganic particle layers

• US 8,932,346 B2
• Filed: 04/23/2009
• Issued: 01/13/2015
• Est. Priority Date: 04/24/2008
• Status: Active Grant

• Current Assignee: Boston Scientific Scimed (Boston Scientific Corporation)
• Original Assignee: Boston Scientific Scimed (Boston Scientific Corporation)
• Inventors: Kuehling, Michael, Seidel, Dominique, Scheuermann, Torsten, Weber, Jan
• Primary Examiner(s): Sweet, Thomas J
• Assistant Examiner(s): PRESTON, REBECCA STRASZHEIM
• Application Number:
  US12/428,775
• Publication Number:
  US 20090269383A1
• Time in Patent Office: 2,091 Days
• Field of Search: 623/1.44, 623/1.46
• US Class Current: 623/1.46
• CPC Class Codes: A61L 2300/61 containing two or more active agents in different layers
• CPC Class Codes: A61L 2300/62 Encapsulated active agents, e.g. emulsified droplets
• CPC Class Codes: A61L 2420/02 Methods for coating medical devices
• CPC Class Codes: A61L 31/08 Materials for coatings
• CPC Class Codes: A61L 31/16 Biologically active materials, e.g. therapeutic substances A61L31/047 takes precedence
• CPC Class Codes: A61P 43/00 Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

An expandable medical device having a particle layer disposed over a reservoir containing a therapeutic agent. The particle layer has a first porosity when the medical device is in the unexpanded configuration and a second porosity when the medical device is in the expanded configuration. The particle layer comprises a plurality of micron-sized or nano-sized particles. In certain embodiments, the particles are not connected to each other, and as such, the different porosities are provided by changes in the spacing between the particles as the medical device is expanded/unexpanded. Also disclosed are medical devices having a particle layer, wherein the particle layer comprises a plurality of encapsulated particles, and methods of coating medical devices with particles.

Claims

1. An expandable medical device having an expanded configuration and an unexpanded configuration, the medical device comprising:

a reservoir containing a therapeutic agent, the reservoir being a polymer layer comprising a polymeric material and the therapeutic agent; and

a particle layer disposed over the reservoir, wherein the particle layer comprises inorganic particles comprised of one or more inorganic materials, the inorganic particles being adhered to the polymer layer, and at least some of the inorganic particles being embedded in the polymer layer;

wherein the particle layer has a first porosity when the medical device is in an unexpanded configuration and a second porosity when the medical device is in an expanded configuration, the first porosity being negligible or zero so as to substantially restrict release of the therapeutic agent from the reservoir, and the second porosity being relatively greater than the first porosity so as to permit a therapeutically effective release profile of the therapeutic agent.

2. The medical device of claim 1, wherein the one or more inorganic materials comprises a metal or metal oxide.

3. The medical device of claim 1, wherein the particles forming the particle layer are not connected to each other, and wherein spaces between the particles enlarge when the medical device is expanded.

4. The medical device of claim 1, wherein the particles form columnar structures.

5. The medical device of claim 4, wherein the columnar structures are not connected to each other, and wherein the spacing between the columnar structures enlarge enlarges when the medical device is expanded.

6. The medical device of claim 1, wherein the particles are nanoparticles.

7. The expandable medical device of claim 1, wherein the particles comprise a core comprising another therapeutic agent and another polymeric material, and wherein the core is coated with a coating comprising another inorganic material.

8. The expandable medical device of claim 7, wherein the therapeutic agent in the reservoir is different from the therapeutic agent in the core of the particles.

9. A method of coating an expandable medical device having an unexpanded configuration and an expanded configuration, the method comprising:

providing a medical device having a reservoir containing a therapeutic agent, the reservoir being a polymer layer comprising a polymeric material and the therapeutic agent;

with the medical device in the expanded configuration, disposing a particle layer over the reservoir, the particle layer comprising inorganic particles comprised of one or more inorganic materials, the inorganic particles being adhered to the polymer layer, and at least some of the inorganic particles being embedded in the polymer layers; and

changing the configuration of the medical device to the unexpanded configuration, the particle layer in the unexpanded configuration having a first porosity, the first porosity being negligible or zero so as to substantially restrict release of the therapeutic agent from the reservoir, and the particle layer on the expanded medical device having a second porosity greater than the first porosity, the second porosity permitting a therapeutically effective release profile of the therapeutic agent.

10. The method of claim 9, wherein the step of disposing the particle layer comprises depositing the particles over the reservoir.

11. The method of claim 10, wherein the particles are deposited by high speed impaction.

12. The method of claim 10, wherein the particles are deposited by roll-coating.

13. The method of claim 10, wherein the particles are deposited by electrostatic spray.

14. The method of claim 10, wherein the particles are deposited by inkjet spray.

15. The method of claim 9, wherein the step of disposing the particle layer comprises depositing the particles onto the polymer layer, and further comprising heating the polymer layer to soften the polymer layer prior to depositing the particles.

16. The method of claim 9, wherein the particle layer, as disposed over the reservoir in the expanded configuration, has a plurality of interstitial spaces between the particles.

17. The method of claim 16, wherein the interstitial spaces become smaller when the medical device is changed to the unexpanded configuration.

18. The method of claim 9, wherein the one or more inorganic materials comprises a metal or metal oxide.

19. The method of claim 9, wherein the particles are not connected to each other.

20. An expandable medical device having an expanded configuration and an unexpanded configuration, the medical device comprising:

a reservoir containing a therapeutic agent; and

a particle layer disposed over the reservoir, wherein the particle layer consists of inorganic particles comprised of one or more inorganic materials;

wherein the particle layer has a first porosity when the medical device is in an unexpanded configuration and a second porosity when the medical device is in an expanded configuration, the first porosity being negligible or zero so as to substantially restrict release of the therapeutic agent from the reservoir, and the second porosity being relatively greater than the first porosity so as to permit a therapeutically effective release profile of the therapeutic agent.

21. A method of coating an expandable medical device having an unexpanded configuration and an expanded configuration, the method comprising:

providing a medical device having a reservoir containing a therapeutic agent;

with the medical device in the expanded configuration, disposing a particle layer over the reservoir, the particle layer consisting of inorganic particles comprised of one or more inorganic materials; and

changing the configuration of the medical device to the unexpanded configuration, the particle layer in the unexpanded configuration having a first porosity, the first porosity being negligible or zero so as to substantially restrict release of the therapeutic agent from the reservoir, and the particle layer on the expanded medical device having a second porosity greater than the first porosity, the second porosity permitting a therapeutically effective release profile of the therapeutic agent.